메뉴 건너뛰기




Volumn 25, Issue 5, 2011, Pages 643-649

Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapy

Author keywords

AIDS; HIV 1; initiation of antiretroviral therapy in young infants; lopinavir ritonavir; pharmacokinetics of antiretrovirals

Indexed keywords

LOPINAVIR PLUS RITONAVIR;

EID: 79952451548     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834403f6     Document Type: Article
Times cited : (27)

References (23)
  • 1
    • 77951065603 scopus 로고    scopus 로고
    • Joint United Nations Programme on HIV/AIDS (UNAIDS) December
    • Joint United Nations Programme on HIV/AIDS (UNAIDS): AIDS Epidemic Update, December 2009. http://data.unaids.org/pub/ Report/2009/JC1700-Epi- Update-2009-en.pdf.
    • (2009) AIDS Epidemic Update
  • 3
    • 56749097184 scopus 로고    scopus 로고
    • CHer Study Team. Early antiretroviral therapy and mortality among HIV-infected infants
    • Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, et al., CHer Study Team. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008; 359:2233-2244.
    • (2008) N Engl J Med , vol.359 , pp. 2233-2244
    • Violari, A.1    Cotton, M.F.2    Gibb, D.M.3    Babiker, A.G.4    Steyn, J.5    Madhi, S.A.6
  • 4
    • 63149144501 scopus 로고    scopus 로고
    • Effect of early antiretroviral therapy on the risk of AIDS/death in HIVinfected infants
    • European Infant Collaboration Group
    • Goetghebuer T, Haelterman E, Le Chenadec J, Dollfus C, Gibb D, Judd A, et al., European Infant Collaboration Group. Effect of early antiretroviral therapy on the risk of AIDS/death in HIVinfected infants. AIDS 2009; 23:597-604.
    • (2009) AIDS , vol.23 , pp. 597-604
    • Goetghebuer, T.1    Haelterman, E.2    Le Chenadec, J.3    Dollfus, C.4    Gibb, D.5    Judd, A.6
  • 6
    • 79953060644 scopus 로고    scopus 로고
    • Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children US Department of Health and Human Services. 23 February [Accessed 1 July 2010]
    • Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children: guidelines for the use of antiretroviral agents in pediatric HIV infection. US Department of Health and Human Services. 23 February 2009; pp. 1-139. http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf. [Accessed 1 July 2010].
    • (2009) Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection , pp. 1-139
  • 8
    • 63449084340 scopus 로고    scopus 로고
    • Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: Pharmacokinetics and 24-week safety and efficacy
    • International Maternal Pediatric Adolescent Clinical Trials Group (IMPAACT) P1030 Team
    • Chadwick EG, Pinto J, Yogev R, Alvero CG, Hughes MD, Palumbo P, et al., International Maternal Pediatric Adolescent Clinical Trials Group (IMPAACT) P1030 Team. Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy. Pediatr Infect Dis J 2009; 28:215-219.
    • (2009) Pediatr Infect Dis J , vol.28 , pp. 215-219
    • Chadwick, E.G.1    Pinto, J.2    Yogev, R.3    Alvero, C.G.4    Hughes, M.D.5    Palumbo, P.6
  • 9
    • 37549058774 scopus 로고    scopus 로고
    • Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results
    • P1030 Team
    • Chadwick EG, Capparelli EV, Yogev R, Pinto JA, Robbins B, Rodman JH, et al., P1030 Team. Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results. AIDS 2008; 22:249-255.
    • (2008) AIDS , vol.22 , pp. 249-255
    • Chadwick, E.G.1    Capparelli, E.V.2    Yogev, R.3    Pinto, J.A.4    Robbins, B.5    Rodman, J.H.6
  • 10
    • 79952455300 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention Growth Charts
    • Centers for Disease Control and Prevention Growth Charts. www.cdc.gov/growthcharts.
  • 11
    • 34248165997 scopus 로고    scopus 로고
    • Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States
    • DOI 10.1086/513871
    • Persaud D, Palumbo P, Ziemniak C, Chen J, Ray SC, Hughes M, et al., Pediatric AIDS Clinical Trials Group P1030 Team. Early archiving andpredominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States. J Infect Dis 2007; 195:1402-1410. (Pubitemid 46717457)
    • (2007) Journal of Infectious Diseases , vol.195 , Issue.10 , pp. 1402-1410
    • Persaud, D.1    Palumbo, P.2    Ziemniak, C.3    Chen, J.4    Ray, S.C.5    Hughes, M.6    Havens, P.7    Purswani, M.8    Gaur, A.H.9    Chadwick, E.G.10
  • 12
    • 0037344230 scopus 로고    scopus 로고
    • Forty-eight-week evaluation of lopinavir/ ritonavir, a new protease inhibitor, in human immunode-ficiency virus-infected children
    • Sáez-Llorens X, Violari A, Deetz CO, Rode RA, Gomez P, Handelsman E, et al. Forty-eight-week evaluation of lopinavir/ ritonavir, a new protease inhibitor, in human immunode-ficiency virus-infected children. Pediatr Infect Dis J 2003; 22:216-224.
    • (2003) Pediatr Infect Dis J , vol.22 , pp. 216-224
    • Sáez-Llorens, X.1    Violari, A.2    Deetz, C.O.3    Rode, R.A.4    Gomez, P.5    Handelsman, E.6
  • 13
    • 0003683811 scopus 로고    scopus 로고
    • Abbott Laboratories, Abbott Park IL Kaletra (lopinavir/ritonavir)
    • Abbott Laboratories, Abbott Park, IL: Product information. Kaletra (lopinavir/ritonavir). Available at http://www.rxabbott. com/pdf/kaletratabpi. pdf.
    • Product Information
  • 14
    • 33646048331 scopus 로고    scopus 로고
    • Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection
    • Italian Register for HIV Infection in Children
    • Chiappini E, Galli L, Tovo PA, Gabiano C, Gattinara GC, Guarino A, et al., Italian Register for HIV Infection in Children. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. AIDS 2006; 20:207-215.
    • (2006) AIDS , vol.20 , pp. 207-215
    • Chiappini, E.1    Galli, L.2    Tovo, P.A.3    Gabiano, C.4    Gattinara, G.C.5    Guarino, A.6
  • 15
    • 49849094748 scopus 로고    scopus 로고
    • Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants
    • Prendergast A, Mphatswe W, Tudor-Williams G, Rakgotho M, Pillay V, Thobakgale C, et al. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants. AIDS 2008; 22:1333-1343.
    • (2008) AIDS , vol.22 , pp. 1333-1343
    • Prendergast, A.1    Mphatswe, W.2    Tudor-Williams, G.3    Rakgotho, M.4    Pillay, V.5    Thobakgale, C.6
  • 16
    • 73249132461 scopus 로고    scopus 로고
    • The changing pattern of adherence to antiretroviral therapy assessed at two time points, 12 months apart, in a cohort of HIV-infected children
    • Giannattasio A, Albano F, Giacomet V, Guarino A. The changing pattern of adherence to antiretroviral therapy assessed at two time points, 12 months apart, in a cohort of HIV-infected children. Expert Opin Pharmacother 2009; 10:2773-2778.
    • (2009) Expert Opin Pharmacother , vol.10 , pp. 2773-2778
    • Giannattasio, A.1    Albano, F.2    Giacomet, V.3    Guarino, A.4
  • 17
    • 70449393899 scopus 로고    scopus 로고
    • Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy
    • Chiappini E, Galli L, Tovo PA, Gabiano C, Lisi C, Bernardi S, et al. Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy. BMC Infect Dis 2009; 9:140.
    • (2009) BMC Infect Dis , vol.9 , pp. 140
    • Chiappini, E.1    Galli, L.2    Tovo, P.A.3    Gabiano, C.4    Lisi, C.5    Bernardi, S.6
  • 18
    • 67651083739 scopus 로고    scopus 로고
    • Immune reconstitution inflammatory syndrome among HIVinfected South African infants initiating antiretroviral therapy
    • Smith K, Kuhn L, Coovadia A, Meyers T, Hu CC, Reitz C, et al. Immune reconstitution inflammatory syndrome among HIVinfected South African infants initiating antiretroviral therapy. AIDS 2009; 23:1097-1107.
    • (2009) AIDS , vol.23 , pp. 1097-1107
    • Smith, K.1    Kuhn, L.2    Coovadia, A.3    Meyers, T.4    Hu, C.C.5    Reitz, C.6
  • 19
    • 0000406478 scopus 로고
    • Rationale for attention to cholesterol levels in children and adolescents
    • National Cholesterol Education Program Expert Panel on Blood Cholesterol Levels in Children and Adolescents
    • National Cholesterol Education Program Expert Panel on Blood Cholesterol Levels in Children and Adolescents: Rationale for attention to cholesterol levels in children and adolescents. Pediatrics 1992; 89(Suppl):528-536.
    • (1992) Pediatrics , vol.89 , Issue.SUPPL. , pp. 528-536
  • 20
    • 48249093075 scopus 로고    scopus 로고
    • Lipid screening and cardiovascular health in childhood
    • The AAP Committee on Nutrition
    • Daniels SR, Greer FR, The AAP Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics 2008; 122:198-208.
    • (2008) Pediatrics , vol.122 , pp. 198-208
    • Daniels, S.R.1    Greer, F.R.2
  • 21
    • 0344760902 scopus 로고    scopus 로고
    • Panel on Antiretroviral Guidelines for Adults and Adolescents U.S. Department of Health and Human Services; December [Accessed 1 July 2010] (p. 156, Appendix B, Table 3)
    • Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. U.S. Department of Health and Human Services; December 2009. pp. 1-161. Available at http:// www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL. pdf. [Accessed 1 July 2010] (p. 156, Appendix B, Table 3).
    • (2009) Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents , pp. 1-161
  • 22
    • 77957951312 scopus 로고    scopus 로고
    • Antiretroviral treatment for children with peripartum nevirapine exposure
    • Palumbo P, Lindsey J, Hughes M, Cotton MF, Bobat R, Meyers T, et al. Antiretroviral treatment for children with peripartum nevirapine exposure. N Engl J Med 2010; 363:1510-1520.
    • (2010) N Engl J Med , vol.363 , pp. 1510-1520
    • Palumbo, P.1    Lindsey, J.2    Hughes, M.3    Cotton, M.F.4    Bobat, R.5    Meyers, T.6
  • 23
    • 77953724252 scopus 로고    scopus 로고
    • National Department of Health, South Africa 2nd ed
    • National Department of Health, South Africa. Guidelines for the management of HIV in Children. 2nd ed. 2010. http://www. who.int/hiv/pub/ paediatric/WHO-Paediatric-ART-guideline- rev-mreport-2008.pdf.
    • (2010) Guidelines for the Management of HIV in Children


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.